CRISPR

UT Dallas Researchers ‘Barcode’ Engineered Cells with Patent-Pending Tech to Protect Biotech IP

by | Sep 27, 2025
The UTD team’s approach adapts a chip-security technique to biology. The breakthrough gives biotech companies a new way to prevent costly misidentification and protect intellectual property.
MORE
16 Biotech Companies in Dallas-Fort Worth ‘Putting the Tech in Bio’ to Drive Breakthroughs

Dallas-Fort Worth is well known for its tech expertise. Now it being recognized as the place where technology meets life science—a convergence that’s driving rapid growth in the biotech ecosystem....

MORE
Form Bio Spins Out of Colossal Bioscience to Offer Scientists the ‘Missing Piece’
by | Sep 27, 2022
Dallas-based Colossal Biosciences, the de-extinction company behind plans to bring back the woolly mammoth and thylacine, developed its own software solution "after reviewing everything available on the market." Now it's sharing the platform with the launch of Form Bio.

The spinout's technology tools can help drive the “entire molecular revolution” that is occurring in the life sciences and biotech space, in addition to bolstering the Lone Star state as a hub for the industry, says Chief Strategy Officer Claire Aldridge.
MORE

UT Southwestern Team Awarded $8.8M to Participate in Genomic Variation Consortium

by | Oct 25, 2021
The team is led by UTSW assistant professor Gary Hon, Ph.D., who developed Mosaic-seq, a gene engineering technique that helped lead to the grant award. UTSW will now become a research partner in a new $185M National Institutes of Health (NIH) initiative to build on findings of the Human Genome Project.
MORE
UTSW Scientist: ‘We Need More Women Thinking Creatively in the Lab and Pushing Science Forward’
by | Oct 8, 2020
This year's Nobel Prize in Chemistry, awarded to two female scientists for the development of CRISPR as a gene-editing tool, is a revolution, according to a pair of UTSW scientists. UTSW's Eric Olson and Rhonda Bassel-Duby use the technology in their work to treat Duchenne muscular dystrophy. Olson also is the co-founder of biotech Exonics Therapeutics, which exited last year in a deal roughly valued at $1B.
MORE
Discovery: UNTHSC Works on More Precise CRISPR, UTSW Uses AI in Depression Research
by | Oct 4, 2019
In this weekly roundup of research and development activity in North Texas, you’ll also find out about how a $427,000 NIH grant is helping a UTA team study the healing of cranial injuries, and how Lexus researchers are creating a high-end audio system.
MORE
CRISPR CAS9 gene editing background
UT Southwestern-Linked Startup Exonics Therapeutics Exits in Deal Valued at $1B
by | Jun 17, 2019
The biotech company uses CRISPR technology licensed from UT Southwestern Medical Center in Dallas, and was co-founded by UTSW researcher and faculty member Eric Olson.
MORE